Sexual Dysfunction in Female Patients with Inflammatory Bowel Disease: An Overview
Taylor Boyd,Punyanganie S de Silva,Sonia Friedman
DOI: https://doi.org/10.2147/CEG.S359367
2022-12-14
Clinical and Experimental Gastroenterology
Abstract:Taylor Boyd, 1 Punyanganie S de Silva, 1, 2 Sonia Friedman 1, 2 1 Harvard Medical School, Boston, MA, USA; 2 Center for Crohn's and Colitis, Brigham and Women's Hospital, Boston, MA, USA Correspondence: Sonia Friedman, 850 Boyston Street, Chestnut Hill, Center for Crohn's and Colitis, Brigham and Women's Hospital, Boston, MA, 02467, USA, +1 617-732-6389, Email Sexual dysfunction is common among females with inflammatory bowel disease and may result in issues involving intimacy, sexual activity, and satisfaction, as well both the formation and preservation of personal relationships. Risk factors for sexual dysfunction include select surgical interventions, medications, mental illnesses, and IBD-related intestinal and extraintestinal comorbidities. In addition, certain demographic factors such as age, disease type and activity may influence the severity of sexual dysfunction. Evaluation of sexual dysfunction may include the use of validated sexual functioning questionnaires, a brief mental health assessment, initial inquiry into vulvovaginal or perineal symptoms, and a gynecologic and GI-focused physical exam. An interdisciplinary care team involving IBD specialists, obstetrician-gynecologists, pelvic floor physical therapists, and primary care physicians may be best suited to provide optimal care and treatment recommendations for patients with sexual dysfunction. Options for management often include pelvic floor physical therapy, biofeedback, and mental health support. Further research is necessary to delineate the impact of IBD activity on sexual dysfunction, to determine if health outcome differences exist depending on surgical approaches utilized during J-pouch operations, and finally to evaluate the care and perceptions of patients with IBD who identify as sexual and gender minorities. Keywords: inflammatory bowel disease, ulcerative colitis, Crohn's disease, sexual dysfunction Inflammatory bowel disease (IBD) is a class of gastrointestinal immune-mediated inflammatory diseases encompassing ulcerative colitis (UC) and Crohn's disease (CD), both of which have been shown to significantly impact health-related quality of life. 1 A number of physical, psychological and social factors contribute to the burden of disease faced by patients with IBD. Both classes of IBD are characterized by relapsing intestinal inflammation frequently resulting in abdominal pain, fatigue, weight loss, and diarrhea. These physical symptoms are often compounded by stress and fear of progression of disease due to the unpredictability and chronicity of IBD. 2 Among females, IBD is often diagnosed between the ages of 20 and 40, a timeline which is in alignment with peak years for body image formation, fostering of intimate relationships, searching for long-term partners, and making decisions regarding family planning. 3 These important milestones may be interrupted by the significant impact of sexual dysfunction (SD), another common complication of IBD. Challenges in sexual health among patients with IBD are complex and multifactorial. Improved clinician awareness and understanding of the etiology, risk factors, and impact of sexual dysfunction for women with IBD may result in improved diagnosis, care, and ultimately better health and wellbeing for this patient population. Sexual dysfunction has three main classifications including impairment in sexual desire, arousal or orgasm, and/or sexual pain. 4 Identification of dysfunction in one or more of these categories requires completion of a thorough physical exam, a detailed medical history and a trusting patient-physician relationship. In addition to these core elements, multiple screening tools are available which may assist in the initial assessment. One tool widely used within the general population is the Female Sexual Function Index (FSFI). 5 The FSFI consists of 19 items and utilizes a 5-point Likert scale to assess 6 primary domains of female sexual function including desire, arousal, lubrication, orgasm, satisfaction, and pain. This scale has been validated in numerous clinical and research settings. 6 The Female Sexual Distress Scale–Revised (FSDS-R) is an alternative screening tool which has demonstrated high test–retest reliability and internal consistency in measuring sexually related personal distress among women. 7 This questionnaire has the added benefit of brevity, with 13 Likert scale questions inquiring about patients' experiences of sexual distress in the past month. Both scales are psychometrically sound and clinically interpretable, however neither are specific for measuring sexual dysfunction in patients with IBD. The IBD-Specific Female Sexual Dysfunction Scale (IBD-FSDS) correlates positively with the FSFI and FSDS -Abstract Truncated-